MedStar Health Advances in the Management of Prostate, Bladder and Kidney Cancers 2021

10 $

‘+ Include: 33 videos + 1 pdf, size: 4.02 GB

+ Target Audience: oncology, pathology, radiation oncology, surgery, urology

Description

+ Include: 33 videos + 1 pdf, size: 4.02 GB

+ Target Audience: oncology, pathology, radiation oncology, surgery, urology

+ Sample video: contact me for sample video

+ Topics:

Agenda.pdf
Keynote Progress in Prostate Cancer Management in 2020.mp4
Keynote Questions and Discussion.mp4
Session I Management of Early-Stage Prostate Cancer – Emerging Role of Focal Therapy for Localized Prostate Cancer.mp4
Session I Management of Early-Stage Prostate Cancer – Frontiers in Imaging in the Pretreatment Setting.mp4
Session I Management of Early-Stage Prostate Cancer – Intro + Retzius-Sparing Robot Assisted Radical Prostatectomy Evolution and Outcomes.mp4
Session I Management of Early-Stage Prostate Cancer – Prostate Cancer Health Disparities.mp4
Session I Management of Early-Stage Prostate Cancer – Questions and Discussion.mp4
Session II Management of High-Risk and Advanced Prostate Cancer – Intro + Personalized Approach to Postoperative Radiation and Hormonal Therapy in Men with Biochemical Recurrence Following Prostatectomy.mp4
Session II Management of High-Risk and Advanced Prostate Cancer – Personalized Approach to Postoperative Radiation and Hormonal Therapy in Men with Biochemical Recurrence Following Prostatectomy.mp4
Session II Management of High-Risk and Advanced Prostate Cancer – Questions and Discussion.mp4
Session II Management of High-Risk and Advanced Prostate Cancer – Radiation for Biochemically-Recurrent and Oligometastatic Prostate Cancer.mp4
Session III Management of Metastatic Castration Resistant Prostate Cancer – Intro + Therapeutic Potential of PARP Inhibition in Prostate Cancer.mp4
Session III Management of Metastatic Castration Resistant Prostate Cancer – New Biology, Novel Approaches and Targeted Therapies for Prostate Cancer.mp4
Session III Management of Metastatic Castration Resistant Prostate Cancer – New Immunotherapeutic Approaches to Advanced Prostate Cancer.mp4
Session III Management of Metastatic Castration Resistant Prostate Cancer – PSMA-Targeted Radionuclide Therapy for Advanced Prostate Cancer.mp4
Session III Management of Metastatic Castration Resistant Prostate Cancer – Questions and Discussion + Closing Remarks Day 1.mp4
Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Intro.mp4
Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Keynote Lecture Targeting the HIF-2-VEGF Axis in RCC.mp4
Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Novel Endpoints and Predictive Biomarkers for RCC.mp4
Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Questions and Discussion.mp4
Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Update on Systemic Therapy for Metastatic ccRCC.mp4
Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Update on the Surgical Management of RCC and the Impact of COVID-19 Pandemic.mp4
Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Update on the Treatment of nccRCC.mp4
Session V Bladder Cancer – Evolving Role of Immunotherapy and Targeted Therapies in the Systemic Management of Urothelial Carcinoma.mp4
Session V Bladder Cancer – Intro.mp4
Session V Bladder Cancer – Novel Approaches to Improve Outcomes in Non-Muscle Invasive Urothelial Carcinoma of the Bladder.mp4
Session V Bladder Cancer – Organ Sparing Cystectomy.mp4
Session V Bladder Cancer – Questions and Discussion + Closing Remarks Day 2.mp4
Session V Bladder Cancer – Radio-sensitization Strategies and Bladder Preservation.mp4
Session V Bladder Cancer – Updates in Systemic Therapy for Bladder Cancers.mp4
Session V Bladder Cancer – Upper Tract Urothelial Carcinoma; Unique Genetics, Biology and Evolving Therapeutics.mp4
Welcome Remarks Day 1.mp4
Welcome Remarks Day 2.mp4

Reviews

There are no reviews yet.

Be the first to review “MedStar Health Advances in the Management of Prostate, Bladder and Kidney Cancers 2021”

Your email address will not be published. Required fields are marked *